Testing Multimedia

Sally is a semi-retired university lecturer living in South Wales. Since being diagnosed with a neuroendocrine tumour in 2009, Sally has experienced many consultations with different clinicians over the years. Sally believes it is an absolute necessity for all NET patients to have access to a specialist NET service. She also feels patient support is crucial for patients living with NETs and has been involved in patient groups and advocacy for many years. 

After graduating from Imperial College, London, Dr Khan completed higher specialist training in Gastroenterology and Internal Medicine in London including Imperial, University College London, Royal Free and Royal Marsden Hospitals. He was awarded a PhD for his research in NETs whilst at the Royal Free/UCL, achieving numerous publications and national/international awards. After a fellowship in Gastrointestinal consequences of cancer at the Royal Marsden, he moved to Cardiff and was appointed as a Consultant Gastroenterologist in 2014 at Cardiff & Vale University Health Board.  

Since 2017, he has successfully led the multi-award-winning transformation of the nationally commissioned Neuroendocrine Cancer service in South Wales. Working through a patient-centred approach, the service has won the UK Patient Experience Network Award and were finalists for BMJ Cancer Team of the Year. It achieved accreditation as a European NET Centre of Excellence in 2022. 

Academically, Dr Khan has various Chief and Principal Investigator roles, with research interests in patient outcomes, NETs, service improvement, and real-world data. He has been involved in digital health projects and currently has leadership roles in the digital transformation of healthcare at local and national levels. Through a range of projects and roles with the British Medical Association and Welsh Government, he champions staff wellbeing, equality, diversity and inclusion, in particular, race equality. 

Dr Zdanowicz is a Senior Consultant at the Department of Obstetrics and Gynecology at Bern University Hospital, Inselspital in Bern. She is also the Clinical Head of the Maternity Unit and is currently completing her subspeciality training in Feto-Maternal Medicine. Her main research areas focus on peripartum hemorrhage and patient blood management, hypertensive disorders in pregnancy as well as prenatal diagnosis in ultrasound.

After obtaining a Bachelor of Science in Biology at the University of Utah in Salt Lake City, USA, Dr Zdanowicz completed her medical studies with a MD at the Ludwig-Maximilians-University in Muenchen, Germany, with clinical training in Australia, Canada, Switzerland and Poland. 

Dr Zdanowicz initiated studies on peripartum hemorrhage and patient blood management at the Department of Obstetrics and Gynecology at Bern University Hospital, Inselspital. She is involved in several interdisciplinary clinical and research projects at the Department of Obstetrics and Gynecology, Bern University Hospital, Inselspital. Her research has been published in international scientific journals and presented at international scientific meetings. Dr Zdanowicz completed a Research Fellowship at the Department of Obstetrics and Prenatal Medicine, University Hospital Hamburg-Eppendorf in Germany in 2021. In addition, she is responsible for simulation-based obstetric training at the Department of Obstetrics and Gynecology at Bern University Hospital, Inselspital.

Homa K. Ahmadzia, MD/MPH is a Maternal-Fetal Medicine specialist and Assistant Professor in the Department of Obstetrics and Gynecology. Dr Ahmadzia completed her undergraduate, medical school education, and Masters of Public Health at The George Washington University. She then completed her residency at Yale University where she was awarded the Outstanding Resident Teaching Award in both her second and third year of residency and also served as Administrative Chief resident. She completed her fellowship in Maternal-Fetal Medicine at Duke University.

Dr Ahmadzia has presented her research at numerous national and regional conferences including the American Institute of Ultrasound in Medicine, The Society for Maternal Fetal Medicine and The American Congress for Obstetricians and Gynecologists. She received the Charles B. Hammond Fund research award to fund her fellowship thesis project. She also attended the Excellence in Clinical Research course and NICHD Young Investigators Conference. During fellowship, she served on the Society of Maternal Fetal Medicine Global Health Committee. She has previously received the Clinical and Translational Science Institute KL2 Mentored Career Development Award through the GW-CNMC partnership with NIH and currently on a K23 Career Mentored Development Award from NHLBI. She has a specific clinic for Pregnancy and Hematology issues at GW. She also has other grant funded research from the FDA and Gates foundation as well as serves as the Medical Monitor for the Maternal-Fetal Medicine Unit Network.

Dr Ahmadzia’s clinical areas of interest include prenatal diagnosis, ultrasonography, management of high risk pregnancies, bleeding disorders and thrombophilias, preconception counseling and infectious diseases. She enjoys taking care of women during pregnancy and hopes to improve perinatal outcomes for women in the US and abroad through her clinical and research interests.

Dr Lars Asmis is Director at the Centre for Perioperative Thrombosis and Haemostasis in Zurich, Switzerland.  He completed his medical training at the University of Bern and has subsequently held positions at Inselspital Bern, University of Geneva and USZ Zurich.  In 2002 he worked as a visiting scientist at Johns Hopkins University in Baltimore, USA.  Dr Asmis has held a number of leadership positions including Co-president of the Swiss Working Party for Hemostasis from 2020 to 2021.  He has authored more than 50 peer-reviewed publications.